Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version

Toshirou Nishida, Seiichi Hirota, Akio Yanagisawa, Yoshinori Sugino, Manabu Minami, Yoshitaka Yamamura, Yoshihide Otani, Yasuhiro Shimada, Fumiaki Takahashi, Tetsuro Kubota

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

Diagnostic and treatment strategies for gastrointestinal stromal tumors (GISTs) have evolved greatly since the introduction of molecularly targeted therapies. Although several clinical practice guidelines are extant, such as those published by the National Comprehensive Cancer Network and the European Society of Medical Oncology, it is not clear as to whether these are appropriate for clinical practice in Japan. Therefore, clinical practice guidelines for the optimal diagnosis and treatment of GIST tailored for the Japanese situation have often been requested. For this reason, the Japanese Clinical Practice Guideline for GIST was proposed by the GIST Guideline Subcommittee, with the official approval of the Clinical Practice Guidelines Committee for Cancer of the Japan Society of Clinical Oncology (JSCO), and was published after assessment by the Guideline Evaluation Committee of JSCO. The GIST Guideline Subcommittee consists of members from JSCO, the Japanese Gastric Cancer Association (JGCA), and the Japanese Study Group on GIST, with the official approval of these organizations. The GIST Guideline Subcommittee is not influenced by any other organizations or third parties. Revision of the guideline may be done periodically, with the approval of the GIST Guideline Subcommittee, either every 3 years or when important new evidence that might alter the optimal diagnosis and treatment of GIST emerges. Here we present the English version of the Japanese Clinical Practice Guideline for GIST prepared by the GIST Guideline Subcommittee.

Original languageEnglish
Pages (from-to)416-430
Number of pages15
JournalInternational Journal of Clinical Oncology
Volume13
Issue number5
DOIs
Publication statusPublished - 2008 Oct

Fingerprint

Gastrointestinal Stromal Tumors
Practice Guidelines
Japan
Guidelines
Medical Oncology
Stomach Neoplasms
Neoplasms

Keywords

  • Clinical practice guideline
  • Diagnosis
  • Gastrointestinal stromal tumor (GIST)
  • KIT protein
  • Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Hematology

Cite this

Nishida, T., Hirota, S., Yanagisawa, A., Sugino, Y., Minami, M., Yamamura, Y., ... Kubota, T. (2008). Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. International Journal of Clinical Oncology, 13(5), 416-430. https://doi.org/10.1007/s10147-008-0798-7

Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan : English version. / Nishida, Toshirou; Hirota, Seiichi; Yanagisawa, Akio; Sugino, Yoshinori; Minami, Manabu; Yamamura, Yoshitaka; Otani, Yoshihide; Shimada, Yasuhiro; Takahashi, Fumiaki; Kubota, Tetsuro.

In: International Journal of Clinical Oncology, Vol. 13, No. 5, 10.2008, p. 416-430.

Research output: Contribution to journalArticle

Nishida, T, Hirota, S, Yanagisawa, A, Sugino, Y, Minami, M, Yamamura, Y, Otani, Y, Shimada, Y, Takahashi, F & Kubota, T 2008, 'Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version', International Journal of Clinical Oncology, vol. 13, no. 5, pp. 416-430. https://doi.org/10.1007/s10147-008-0798-7
Nishida, Toshirou ; Hirota, Seiichi ; Yanagisawa, Akio ; Sugino, Yoshinori ; Minami, Manabu ; Yamamura, Yoshitaka ; Otani, Yoshihide ; Shimada, Yasuhiro ; Takahashi, Fumiaki ; Kubota, Tetsuro. / Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan : English version. In: International Journal of Clinical Oncology. 2008 ; Vol. 13, No. 5. pp. 416-430.
@article{b0fc89c2f1fe466896e3a436feacbfa4,
title = "Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version",
abstract = "Diagnostic and treatment strategies for gastrointestinal stromal tumors (GISTs) have evolved greatly since the introduction of molecularly targeted therapies. Although several clinical practice guidelines are extant, such as those published by the National Comprehensive Cancer Network and the European Society of Medical Oncology, it is not clear as to whether these are appropriate for clinical practice in Japan. Therefore, clinical practice guidelines for the optimal diagnosis and treatment of GIST tailored for the Japanese situation have often been requested. For this reason, the Japanese Clinical Practice Guideline for GIST was proposed by the GIST Guideline Subcommittee, with the official approval of the Clinical Practice Guidelines Committee for Cancer of the Japan Society of Clinical Oncology (JSCO), and was published after assessment by the Guideline Evaluation Committee of JSCO. The GIST Guideline Subcommittee consists of members from JSCO, the Japanese Gastric Cancer Association (JGCA), and the Japanese Study Group on GIST, with the official approval of these organizations. The GIST Guideline Subcommittee is not influenced by any other organizations or third parties. Revision of the guideline may be done periodically, with the approval of the GIST Guideline Subcommittee, either every 3 years or when important new evidence that might alter the optimal diagnosis and treatment of GIST emerges. Here we present the English version of the Japanese Clinical Practice Guideline for GIST prepared by the GIST Guideline Subcommittee.",
keywords = "Clinical practice guideline, Diagnosis, Gastrointestinal stromal tumor (GIST), KIT protein, Therapeutics",
author = "Toshirou Nishida and Seiichi Hirota and Akio Yanagisawa and Yoshinori Sugino and Manabu Minami and Yoshitaka Yamamura and Yoshihide Otani and Yasuhiro Shimada and Fumiaki Takahashi and Tetsuro Kubota",
year = "2008",
month = "10",
doi = "10.1007/s10147-008-0798-7",
language = "English",
volume = "13",
pages = "416--430",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan

T2 - English version

AU - Nishida, Toshirou

AU - Hirota, Seiichi

AU - Yanagisawa, Akio

AU - Sugino, Yoshinori

AU - Minami, Manabu

AU - Yamamura, Yoshitaka

AU - Otani, Yoshihide

AU - Shimada, Yasuhiro

AU - Takahashi, Fumiaki

AU - Kubota, Tetsuro

PY - 2008/10

Y1 - 2008/10

N2 - Diagnostic and treatment strategies for gastrointestinal stromal tumors (GISTs) have evolved greatly since the introduction of molecularly targeted therapies. Although several clinical practice guidelines are extant, such as those published by the National Comprehensive Cancer Network and the European Society of Medical Oncology, it is not clear as to whether these are appropriate for clinical practice in Japan. Therefore, clinical practice guidelines for the optimal diagnosis and treatment of GIST tailored for the Japanese situation have often been requested. For this reason, the Japanese Clinical Practice Guideline for GIST was proposed by the GIST Guideline Subcommittee, with the official approval of the Clinical Practice Guidelines Committee for Cancer of the Japan Society of Clinical Oncology (JSCO), and was published after assessment by the Guideline Evaluation Committee of JSCO. The GIST Guideline Subcommittee consists of members from JSCO, the Japanese Gastric Cancer Association (JGCA), and the Japanese Study Group on GIST, with the official approval of these organizations. The GIST Guideline Subcommittee is not influenced by any other organizations or third parties. Revision of the guideline may be done periodically, with the approval of the GIST Guideline Subcommittee, either every 3 years or when important new evidence that might alter the optimal diagnosis and treatment of GIST emerges. Here we present the English version of the Japanese Clinical Practice Guideline for GIST prepared by the GIST Guideline Subcommittee.

AB - Diagnostic and treatment strategies for gastrointestinal stromal tumors (GISTs) have evolved greatly since the introduction of molecularly targeted therapies. Although several clinical practice guidelines are extant, such as those published by the National Comprehensive Cancer Network and the European Society of Medical Oncology, it is not clear as to whether these are appropriate for clinical practice in Japan. Therefore, clinical practice guidelines for the optimal diagnosis and treatment of GIST tailored for the Japanese situation have often been requested. For this reason, the Japanese Clinical Practice Guideline for GIST was proposed by the GIST Guideline Subcommittee, with the official approval of the Clinical Practice Guidelines Committee for Cancer of the Japan Society of Clinical Oncology (JSCO), and was published after assessment by the Guideline Evaluation Committee of JSCO. The GIST Guideline Subcommittee consists of members from JSCO, the Japanese Gastric Cancer Association (JGCA), and the Japanese Study Group on GIST, with the official approval of these organizations. The GIST Guideline Subcommittee is not influenced by any other organizations or third parties. Revision of the guideline may be done periodically, with the approval of the GIST Guideline Subcommittee, either every 3 years or when important new evidence that might alter the optimal diagnosis and treatment of GIST emerges. Here we present the English version of the Japanese Clinical Practice Guideline for GIST prepared by the GIST Guideline Subcommittee.

KW - Clinical practice guideline

KW - Diagnosis

KW - Gastrointestinal stromal tumor (GIST)

KW - KIT protein

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=54849442097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54849442097&partnerID=8YFLogxK

U2 - 10.1007/s10147-008-0798-7

DO - 10.1007/s10147-008-0798-7

M3 - Article

C2 - 18946752

AN - SCOPUS:54849442097

VL - 13

SP - 416

EP - 430

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 5

ER -